Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological Effects and Mechanisms of Action of Myricanol.

Molecules (Basel, Switzerland)·2026
Same author

Protocol for the standardized design of Morris water maze experiments and statistical analysis using SPSS.

STAR protocols·2026
Same author

Neg-entropy is the true drug target for chronic diseases.

Acta pharmaceutica Sinica. B·2026
Same author

Suppression of hepatosteatosis by isarubrolone C through AMPK-dependent regulation of lipophagy and lipid metabolism.

Metabolism: clinical and experimental·2025
Same author

Anticancer, Anti-Inflammatory, and Acute Toxicological Evaluation of the Novel Berberine Derivative BN-7.

Chemistry & biodiversity·2025
Same author

Effects of Chronic Moderate Alcohol Intake on Metabolic Phenotypes and Gut Microbiota in Lean and Obese Mice with Distinct Dietary Structures.

Nutrients·2025

Related Experiment Video

Updated: Apr 18, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

12.1K

A zebrafish model for subgenomic hepatitis C virus replication.

Cun-Bao Ding1, Ye Zhao1, Jing-Pu Zhang1

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P.R. China.

International Journal of Molecular Medicine
|January 10, 2015
PubMed
Summary
This summary is machine-generated.

A novel zebrafish model effectively replicates hepatitis C virus (HCV) RNA, aiding liver disease research. This model also shows promise for discovering new anti-HCV drugs.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.9K
Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

10.8K

Related Experiment Videos

Last Updated: Apr 18, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

12.1K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.9K
Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

10.8K

Area of Science:

  • Virology
  • Genetics
  • Hepatology

Background:

  • Persistent hepatitis C virus (HCV) infection is a primary driver of hepatocellular carcinoma.
  • Studying HCV pathogenesis is challenging due to the lack of suitable small animal models.
  • Zebrafish offer genetic similarity to mammals and experimental tractability.

Purpose of the Study:

  • To establish and validate a zebrafish model for analyzing HCV replication mechanisms.
  • To assess the utility of this model for drug screening against HCV.

Main Methods:

  • Constructed a HCV sub-replicon with essential viral sequences and an EGFP reporter gene under the mHNF4 promoter.
  • Microinjected the construct into zebrafish larvae and monitored EGFP expression in the liver.
  • Confirmed HCV gene expression and RNA replication using RT-PCR, Western blot, and in situ hybridization.
  • Tested the efficacy of ribavirin and oxymatrine in inhibiting HCV replication in the zebrafish model.

Main Results:

  • Successfully established a zebrafish model that demonstrates HCV sub-replicon replication, primarily in the liver.
  • Observed gene expression alterations in zebrafish larvae similar to those in human liver cells during HCV infection.
  • Demonstrated significant inhibition of HCV sub-replicon replication by clinically used drugs, ribavirin and oxymatrine.

Conclusions:

  • The developed zebrafish model provides a novel, simple in vivo system for studying HCV replication.
  • This model holds potential for advancing the understanding of HCV pathogenesis and facilitating the discovery of new anti-HCV therapeutics.